Besins Hlthcare Company Profile
✉ Email this page to a colleague
What is the competitive landscape for BESINS HLTHCARE, and when can generic versions of BESINS HLTHCARE drugs launch?
BESINS HLTHCARE has two approved drugs.
There are eight US patents protecting BESINS HLTHCARE drugs.
There are thirty-six patent family members on BESINS HLTHCARE drugs in twenty-nine countries.
Drugs and US Patents for Besins Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-003 | Sep 7, 2012 | DISCN | Yes | No | 8,466,136 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Besins Hlthcare | ANDROGEL | testosterone | GEL, METERED;TRANSDERMAL | 022309-001 | Apr 29, 2011 | AB | RX | Yes | Yes | 8,741,881 | ⤷ Sign Up | ⤷ Sign Up | |||
Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 021015-001 | Feb 28, 2000 | DISCN | Yes | No | ⤷ Sign Up | ⤷ Sign Up | |||||
Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-003 | Sep 7, 2012 | DISCN | Yes | No | 8,729,057 | ⤷ Sign Up | Y | ⤷ Sign Up | |||
Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-002 | Sep 7, 2012 | DISCN | Yes | No | 8,466,138 | ⤷ Sign Up | ⤷ Sign Up | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Expired US Patents for Besins Hlthcare
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | Patent No. | Patent Expiration |
---|---|---|---|---|---|---|---|
Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 021015-001 | Feb 28, 2000 | 6,503,894*PED | ⤷ Sign Up |
Besins Hlthcare | ANDROGEL | testosterone | GEL, METERED;TRANSDERMAL | 022309-001 | Apr 29, 2011 | 6,503,894*PED | ⤷ Sign Up |
Besins Hlthcare | ANDROGEL | testosterone | GEL, METERED;TRANSDERMAL | 021015-003 | Sep 26, 2003 | 9,125,816*PED | ⤷ Sign Up |
Besins Hlthcare | ANDROGEL | testosterone | GEL;TRANSDERMAL | 022309-002 | Sep 7, 2012 | 9,132,089*PED | ⤷ Sign Up |
Besins Hlthcare | ANDROGEL | testosterone | GEL, METERED;TRANSDERMAL | 021015-003 | Sep 26, 2003 | 6,503,894*PED | ⤷ Sign Up |
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >Patent No. | >Patent Expiration |
Paragraph IV (Patent) Challenges for BESINS HLTHCARE drugs
Drugname | Dosage | Strength | Tradename | Submissiondate |
---|---|---|---|---|
➤ Subscribe | Gel | 1.62% | ➤ Subscribe | 2012-04-06 |
➤ Subscribe | Gel Metered-dose Pump | 1% | ➤ Subscribe | 2008-12-19 |
➤ Subscribe | Gel | 1.62% (1.25 g and 2.5 g packets) | ➤ Subscribe | 2013-06-19 |
International Patents for Besins Hlthcare Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
Georgia, Republic of | P20125432 | ⤷ Sign Up |
Brazil | PI0617294 | ⤷ Sign Up |
Morocco | 29941 | ⤷ Sign Up |
Hong Kong | 1117417 | ⤷ Sign Up |
European Patent Office | 3456329 | ⤷ Sign Up |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.